Percutaneous access devices (PAD), bandages, or other implantable medical devices are provided that are equipped with filters, environmental controls, and sensors that promote the formation of a natural biologic seal between the skin and the device to form a barrier to microbial invasion into the body. Levels of humidity and pressure are monitored and dynamically controlled to optimize wound closure about an implanted device or when a PAD is not present a wound itself. Methods and systems for actively assessing wound closure are incorporated into the design of percutaneous skin access devices (PAD), bone anchors, or a wound dressing or bandage alone without at PAD. Pressure and humidity sensors provide active feedback for making changes to the ecology of the wound site or PAD insertion site. A filter is used to aerate the wound while also preventing pathogens in the ambient air from reaching the wound.

The wound treatment apparatus combines an internal negative pressure (vacuum) pump and an internal positive pressure (compressor) pump connectable to an external oxygen supply for providing both negative pressure wound therapy and hyperbaric oxygen wound therapy to a wound site. The apparatus also includes a user interface operatively connected to an electronic controller that monitors and actuates the vacuum and compressor pumps. The user interface and controller enables the apparatus to provide multiple modes of operation and the ability to selectively change between negative pressure therapy operational modes and hyperbaric oxygen operational modes.

Systems, methods, and apparatuses are presented that facilitate the provision of reduced pressure to a tissue site by using a delivery-and-fluid-storage bridge, which separates liquids and gases and provides a flow path for reduced pressure. In one instance, a delivery-and-fluid-storage bridge includes a delivery manifold for delivering reduced pressure to a treatment manifold at the tissue site and an absorbent layer proximate the delivery manifold adapted to receive and absorb liquids. The delivery manifold and the absorbent layer are encapsulated in an encapsulating pouch. A first aperture is formed proximate a first longitudinal end of the delivery-and-fluid-storage bridge for fluidly communicating reduced pressure to the delivery manifold from a reduced-pressure source, and a second aperture is formed on a patient-facing side of the delivery-and-fluid-storage bridge. Reduced pressure is transferred to the tissue site via the second aperture. Other systems, apparatuses, and methods are disclosed.

In some embodiments, a negative pressure wound therapy system can detect and classify one or more operational conditions, including detection of a wound bleeding. The system can react to detection of blood by providing an indication, reducing the intensity or stopping therapy, releasing negative pressure, etc. In certain embodiments, the system can detect one or more additional operational conditions, such as change in vacuum pressure, gas leak rate change, exudate flow rate change, water flow rate change, presence of exudate, presence of water, etc. The system can detect and distinguish between different operational conditions and provide indication or take remedial action.

Systems, apparatuses, and methods for providing negative pressure and/or instillation fluids to a tissue site and sensing properties of fluids at a tissue site are disclosed. Systems, apparatuses, and methods for wirelessly activating and pairing a sensing device with a wireless communication device and/or therapy device to transfer sensor data from the tissue site is also disclosed.

A wound management system (WMS) is provided that includes dressings, bandages, or implantable medical devices that are equipped with filters, environmental controls, and sensors that promote the formation of a natural biologic seal between the skin and the dressing to form a barrier to microbial invasion into the body that accelerates healing and mitigates wound or exit site infection. Percutaneous access devices (PAD) used with the WMS or other devices including peritoneal dialysis (PD) catheters, Steinman pin, Kirschner wires, and chronic indwelling venous access catheters that require skin penetration. The WMS minimizes risk of exit site infection by reducing the bioburden in the exit tunnel environment in the acute and subacute phases of the PD catheter post-implant. Visualization of the wound without taking off the dressing is provided via a window in the wound area or exit-site to visually monitor for signs of infection and the presence of exudate.

A releasable connector for a negative pressure wound therapy system having a drape and a tube includes a base and a tube fitting. The base is configured to be coupled to the drape such that a substantially air-tight seal is formed between the base and the drape. The base includes a base locking member. The tube fitting is configured to be coupled to the tube such that a substantially air-tight seal is formed between the tube fitting and the tube. The tube fitting includes a tube locking member. The tube fitting is further configured to be selectively coupled to the base through an interaction between the tube locking member and the base locking member such that a substantially air-tight seal is formed between the tube fitting and the base.

The present disclosure relates generally to wound dressings and reduced-pressure wound dressing apparatuses that detect the presence of proteases in a wound upon application. The wound dressings and the reduced-pressure wound dressing apparatus of the present technology can be a visual indicator of the presence of proteases in a wound; and a visual indicator of the wounds healing status.

A device comprising: (a) a housing; (b) one or more pumps located within the housing, the one or more pumps configured to create a negative pressure and move fluid; (c) one or more connectors located at least partially within in the housing; (d) internal fluid paths connecting the one or more pumps to the one or more connectors; (e) one or more reservoirs connected to the one or more connectors, the one or more reservoirs being configured to collect the fluid moved by the one or more pumps; and (f) a processor configured to:(i) calculate a total volume of fluid collected in the one or more reservoirs; and (ii) indicate that the one or more reservoirs are full; wherein the fluid moved is a fluid from a wound or incision.

The wound treatment apparatus combines an internal negative pressure (vacuum) pump and an internal positive pressure (compressor) pump connectable to an external oxygen supply for providing both negative pressure wound therapy and hyperbaric oxygen wound therapy to a wound site. The apparatus also includes a user interface operatively connected to an electronic controller that monitors and actuates the vacuum and compressor pumps. The user interface and controller enables the apparatus to provide multiple modes of operation and the ability to selectively change between negative pressure therapy operational modes and hyperbaric oxygen operational modes.